Results 41 to 50 of about 545,251 (263)

Impacts of the COVID-19 Pandemic on Public Hospitals of Different Levels: Six-Month Evidence from Shanghai, China

Risk Management and Healthcare Policy, 2021
Yuqian Chen,1 Miao Cai,2 Zhipeng Li,3 Xiaojun Lin,4,5 Linan Wang6 1Department of Health Policy Research, Shanghai Health Development Research Center, Shanghai, People’s Republic of China; 2Department of Epidemiology, School of Public Health, Sun Yat-sen ...
Chen Y, Cai M, Li Z, Lin X, Wang L
doaj  

General practitioner consultation for postmenopausal bleeding after COVID‐19 vaccination—a self‐controlled cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aims The incidence of postmenopausal bleeding (PMB) has been increasing over the past years. Little is known about the risk of PMB after COVID‐19 vaccination. Our study aimed to investigate this based on routine general practitioner (GP) healthcare data from the Netherlands.
Rana Jajou, Eugène P. van Puijenbroek, Renee Veldkamp, Jetty A. Overbeek, Florence P. A. M. van Hunsel, Agnes C. Kant   +5 more
wiley   +1 more source

Executive and financial manager’s awareness of economic issues in private and public hospitals in Shiraz

Journal of Health Management & Informatics, 2014
Introduction: Managers, as the members of decision making team in hospitals, are required to understand economic issues In order to increase their knowledge, make better decisions making, and bring about economic growth in hospitals.
Tayebe Hoseinpur, Nahid Hatam, Abdoslaeh Jafari, Maryam Najibi, Hajar Dehghan, Rita Rezaee   +5 more
doaj  

Goodbye Charity Hospital

Anthropologie & Santé, 2018
This think-piece presents an exploratory research conducted in New Orleans in February 2015. I took great interest in the history – distant and recent – of Charity Hospital, a big public hospital of New Orleans parish established in 1736 which provided ...
Fanny Chabrol
doaj   +1 more source

A single‐centre analysis of a biosimilar switching programme for adalimumab in inflammatory bowel disease

British Journal of Clinical Pharmacology, EarlyView.
Aims Amgevita is a licensed biosimilar to adalimumab, having demonstrated high pharmacokinetic and clinical similarity to Humira. Switching to a lower‐cost medicine may elicit a nocebo effect, whereby expectations of poorer efficacy impact outcomes despite pharmacological similarity. This prospective cohort study examined clinical and economic outcomes
Louise Rabbitt, Áine Keogh, Linda Duane, John Ferguson, Anna Hobbins, Brian E. McGuire, Patrick Gillespie, Laurence J. Egan   +7 more
wiley   +1 more source

The Cost of Internal and Neurosurgery ICUs in a Selected Teaching Hospital: A Case Study

پژوهش‌های سلامت‌محور, 2019
The Cost of Internal and Neurosurgery ICUs in a Selected Teaching Hospital: A Case Study   Mehrinezhad Safieh1, Sarabi Asiabar Ali2, Rezapour Aziz3, Shokri Anahita4*, Meshkani Zahra4,  Alipour Vahid5, Emadi Chachkami Seyed Zeia6   1.
Safieh Mehrinekhad, Ali Sarabi Asiabar, Aziz Rezapour, Anahita Shokri, Zahra Meshkani, Vahid Alipour, Seyed Zeia Emadi Chachkami   +6 more
doaj  

Impact of surgical complications on hospital costs and revenues: retrospective database study of Medicare claims

Journal of Comparative Effectiveness Research, 2023
Aim: To compare the length of stay, hospital costs and hospital revenues for Medicare patients with and without a subset of potentially preventable postoperative complications after major noncardiac surgery.
Samer Haidar, Reynaldo Vazquez, Goran Medic   +2 more
doaj   +1 more source

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges

Clinical Pharmacology &Therapeutics, EarlyView.
Barriers to incorporating pharmacogenetics into routine clinical practice in the United States are well documented. Initial surveys by the Clinical Pharmacogenetics Implementation Consortium (CPIC) in 2009 and 2010 identified barriers across four key domains that have hindered the widespread adoption of clinical pharmacogenetic testing.
D. Max Smith, Michael P. Douglas, Christina L. Aquilante, Patricia A. Deverka, Beth Devine, Henry M. Dunnenberger, Philip E. Empey, Daniel L. Hertz, Andrew A. Monte, Ann M. Moyer, Jai N. Patel, Victoria M. Pratt, Loren Saulsberry, Stuart A. Scott, Deepak Voora, Erica L. Woodahl, Michelle Whirl‐Carrillo, Akinyemi Oni‐Orisan, on behalf of the Pharmacogenomics Global Research Network (PGRN) Publications Committee   +18 more
wiley   +1 more source

Comparing the Results of two Cost Sharing Approaches in Calculating the Cost of Hospital Services: a case study

پژوهش‌های سلامت‌محور, 2018
Comparing the Results of two Cost Sharing Approaches in Calculating the Cost of Hospital Services: a case study   Alipour Vahid1, Rezapour Aziz2, Meshkani Zahra3, Farabi Hiro3*, Mazdaki Alireza4, Hakimi Narges5   1.
Vahid Alipour, Aziz Rezapour, Zahra Meshkani, Hiro Farabi, Alireza Mazdaki, Narges Hakimi   +5 more
doaj  

Tackling Environmental Impact: A New Support Tool for Sustainable Healthcare Waste Management

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT This study proposes a novel framework integrating Environmental Risk Assessment (ERA) and Material Flow Analysis (MFA) within the Deming Cycle framework to address this gap. While valuable tools, ERA and MFA offer limited perspectives on environmental impact when used alone.
Carlotta D'Alessandro, Katarzyna Szopik‐Depczyńska, Raffaella Taddeo, Katarzyna Cheba, Giuseppe Ioppolo   +4 more
wiley   +1 more source